217 related articles for article (PubMed ID: 37478900)
1. Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte-Keratinocyte Transplantation Surgery for Vitiligo.
Refat MA; Strassner JP; Frisoli ML; Rashighi M; Richmond J; Nada E; Saleh R; El-Hamd MA; Goldberg D; Mahmoud BH; Harris JE
J Invest Dermatol; 2023 Nov; 143(11):2275-2282.e6. PubMed ID: 37478900
[TBL] [Abstract][Full Text] [Related]
2. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
3. Uncommon responses of segmental vitiligo to melanocyte-keratinocyte transplantation procedure.
Isedeh P; Al Issa A; Lim HW; Mulekar SS; Mulekar SV
J Cutan Med Surg; 2015; 19(2):177-81. PubMed ID: 25775633
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation.
Zhang D; Wei X; Hong W; Fu L; Qian G; Xu AE
Aging (Albany NY); 2021 Feb; 13(4):5415-5425. PubMed ID: 33582653
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
[TBL] [Abstract][Full Text] [Related]
6. Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review.
Maghfour J; Bardhi R; Huggins R; Hamzavi IH; Mohammad TF
Dermatology; 2023; 239(5):828-831. PubMed ID: 37231873
[TBL] [Abstract][Full Text] [Related]
7. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
[TBL] [Abstract][Full Text] [Related]
8. Recipient site preparation by cryoblebbing in melanocyte keratinocyte transplantation procedure over the fingers in vitiligo: A pilot study.
El Hawary M; Bassiouny DA; Esmat S; Sobhi R; Saleh MA; AbdelHalim D; Hegazy R; Gawdat H; Ragab N; Samir N; Sany I
Dermatol Ther; 2020 Nov; 33(6):e14199. PubMed ID: 32798282
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of noncultured melanocyte-keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence.
Vakharia PP; Lee DE; Khachemoune A
Int J Dermatol; 2018 Jul; 57(7):770-775. PubMed ID: 29318598
[TBL] [Abstract][Full Text] [Related]
10. Practical guidelines for the treatment of vitiligo with the melanocyte-keratinocyte transplantation procedure.
Yousif J; Ceresnie MS; Hamzavi IH; Mohammad TF
Arch Dermatol Res; 2023 Dec; 316(1):10. PubMed ID: 38038734
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of autologous non-cultured melanocyte keratinocyte transplantation in vitiligo and nevus depigmentosus.
Sritanyarat T; Wongpraparut C; Jansuwan N; Yothachai P; Nuntawisuttiwong N; Silpa-Archa N
J Dermatolog Treat; 2022 Mar; 33(2):935-940. PubMed ID: 32643482
[TBL] [Abstract][Full Text] [Related]
12. Non-cultured melanocyte/keratinocyte transplantation for the treatment of stable vitiligo on the face: report of two cases.
Ramos MG; Ramos DG; Gontijo G; Ramos CG; Rocha TN; Rocha RH
An Bras Dermatol; 2013; 88(5):811-3. PubMed ID: 24173191
[TBL] [Abstract][Full Text] [Related]
13. Autologous noncultured melanocyte-keratinocyte transplantation in stable vitiligo: A randomized comparative study of recipient site preparation by two techniques.
Gupta S; Relhan V; Garg VK; Sahoo B
Indian J Dermatol Venereol Leprol; 2019; 85(1):32-38. PubMed ID: 29998861
[TBL] [Abstract][Full Text] [Related]
14. Fractional versus full ablative CO
Jamal-Edine AM; El-Barbary RA; Moftah NH
J Cosmet Dermatol; 2022 Apr; 21(4):1506-1513. PubMed ID: 34213808
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo.
Ramos MG; Ramos DG; Ramos CG
An Bras Dermatol; 2017; 92(3):312-318. PubMed ID: 29186240
[TBL] [Abstract][Full Text] [Related]
16. A study of autologous melanocyte transfer in treatment of stable vitiligo.
Pandya V; Parmar KS; Shah BJ; Bilimoria FE
Indian J Dermatol Venereol Leprol; 2005; 71(6):393-7. PubMed ID: 16394479
[TBL] [Abstract][Full Text] [Related]
17. Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation.
Rao A; Gupta S; Dinda AK; Sharma A; Sharma VK; Kumar G; Mitra DK; Prashant CK; Singh G
Br J Dermatol; 2012 Jun; 166(6):1230-6. PubMed ID: 22329760
[TBL] [Abstract][Full Text] [Related]
18. The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation.
Falabella R; Arrunategui A; Barona MI; Alzate A
J Am Acad Dermatol; 1995 Feb; 32(2 Pt 1):228-32. PubMed ID: 7829707
[TBL] [Abstract][Full Text] [Related]
19. Genital vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV; Al Issa A; Al Eisa A; Asaad M
Dermatol Surg; 2005 Dec; 31(12):1737-9; discussion 1740. PubMed ID: 16336903
[TBL] [Abstract][Full Text] [Related]
20. Clinical and treatment characteristics determining therapeutic outcome in patients undergoing autologous non-cultured outer root sheath hair follicle cell suspension for treatment of stable vitiligo.
Vinay K; Dogra S; Parsad D; Kanwar AJ; Kumar R; Minz RW; Saikia UN
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):31-7. PubMed ID: 24628828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
